The Barbara Ann Karmanos Cancer Institute — Detroit, Michigan

The Barbara Ann Karmanos Cancer Institute is a clinical research site located in Detroit, Michigan, United States 48201.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

The Barbara Ann Karmanos Cancer Institute has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Chronic Phase Chronic Myelogenous Leukemia, Solid Tumor, Adult, HCC - Hepatocellular Carcinoma.

Sponsors: Medical College of Wisconsin, Indaptus Therapeutics, Inc.

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Barbara Ann Karmanos Cancer Institute?

The Barbara Ann Karmanos Cancer Institute has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Barbara Ann Karmanos Cancer Institute conducted?

The Barbara Ann Karmanos Cancer Institute has 2 clinical trials on record, with 2 currently active. Their work covers Chronic Phase Chronic Myelogenous Leukemia, Solid Tumor, Adult, HCC - Hepatocellular Carcinoma.

Is The Barbara Ann Karmanos Cancer Institute accredited by Crixeo Health?

The Barbara Ann Karmanos Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The Barbara Ann Karmanos Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.